4 Quotes by Cui Bin

An increasing number of Chinese pharmaceutical companies, in particular privately-owned firms in coastal areas, are eyeing the international market.

This is the first time the growth rate surpassed the country's overall export growth.

Domestic companies are working to counteract the on-going dumping claims. They understand that they might totally lose the target market if they do not respond.

Chinese pharmaceutical companies are seeing more anti-dumping or anti-subsidy cases. The conflicts are spreading to some major exports.